Editing Steatorrhea (section)

===Associated diseases===
* Conditions affecting the [[pancreas]].  [[Exocrine pancreatic insufficiency]]<ref name="pmid24259956">{{cite journal |vauthors=Lindkvist B |title=Diagnosis and treatment of pancreatic exocrine insufficiency |journal=World J. Gastroenterol. |volume=19 |issue=42 |pages=7258–66 |year=2013 |pmid=24259956 |pmc=3831207 |doi=10.3748/wjg.v19.i42.7258 |type=Review |doi-access=free }}</ref> can be caused by chronic [[pancreatitis]], [[cystic fibrosis]] and [[pancreatic cancer]] (if it obstructs biliary outflow).<ref name="Handbook"/>
* Conditions affecting [[bile salts]].  Obstruction of the [[bile ducts]] by [[gallstones]] ([[choledocholithiasis]]), [[primary sclerosing cholangitis]], [[liver damage]] ([[hepatitis]], intrahepatic [[cholestasis]]), [[hypolipidemic]] drugs, or changes following [[gallbladder]] removal ([[cholecystectomy]]).<ref name="Handbook"/>
* Conditions producing intestinal [[malabsorption]].  These include [[celiac disease]], [[bacterial overgrowth]], [[tropical sprue]], [[giardiasis]] (a protozoan parasite infection), [[Zollinger-Ellison syndrome]], [[short bowel syndrome]], [[inflammatory bowel disease]] and [[abetalipoproteinemia]].<ref name="Handbook"/><ref name="pmid20626336">{{cite journal |last1=Moutzouri |first1=Elisavet |last2=Elisaf |first2=Moses |last3=Liberopoulos |first3=N. Evangelos |year=2011 |title=Hypocholesterolemia |journal=Current Vascular Pharmacology |volume=9 |issue=2 |pages=200–12 |doi=10.2174/157016111794519354 |pmid=20626336}}</ref>
* Other causes: Drugs that can produce steatorrhea include [[orlistat]], a slimming pill, or as adverse effect of [[octreotide]] or [[lanreotide]], used to treat [[acromegaly]] or other [[neuroendocrine tumors]].<ref>{{cite journal|last1=Dogliotti|first1=L|last2=Tampellini|first2=M|last3=Stivanello|first3=M|last4=Gorzegno|first4=G|last5=Fabiani|first5=L|title=The clinical management of neuroendocrine tumors with long-acting repeatable (LAR) octreotide: comparison with standard subcutaneous octreotide therapy|journal=Annals of Oncology|date=2001|volume=12|issue=Suppl 2|pages=S105–9|pmid=11762334|doi=10.1093/annonc/12.suppl_2.s105|doi-access=}}</ref>  It can be found in [[Graves' disease]] / [[hyperthyroidism]].<ref name="Handbook"/>